This guidance provides additional information on the conduct of studies performed using Test Guidelines 451, 452 and Test Guideline 453. Its objective is to assist users of the TGs to select the most appropriate methodology to assess the chronic toxicity and carcinogenicity of a test chemical so that particular data requirements can be met while reducing animal usage if possible/appropriate.
Guidance Document 116 on the Conduct and Design of Chronic Toxicity and Carcinogenicity Studies, Supporting Test Guidelines 451, 452 and 453
Second edition
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Report10 August 202653 Pages
-
10 August 2026179 Pages
-
15 December 2025169 Pages
-
Report3 December 2025136 Pages
Related publications
-
Report10 August 202653 Pages
-
10 August 2026179 Pages
-
2 July 202651 Pages
-
Report2 July 202631 Pages